PD_Packaging Digest

Packaging Digest, Fall 2016

Issue link: http://dc.cn.ubm-us.com/i/737088

Contents of this Issue


Page 34 of 51

35 www.PackagingDigest.com FALL 2016 // BEST PRACTICES from the simple blister/wallet pack to what now is the approved commercial package, a child-resistant, senior- friendly format that aids patient compliance. "Troughout the clinical trial process, Amicus engaged with patient focus groups to gather their valuable feedback on the packaging format," says Hunter. "Tis, together with input from the Almac multi- disciplinary project team (including packaging design, production, and engineering) and the specialist packaging personnel at the [Dosepak] component supplier WestRock, the fnal pack format was agreed." Te team's challenge: design the package in a way that would encourage patient compliance with an "every other day" dosing regimen. Amicus together with Almac's in- house packaging team designed a compact monthly wallet pack. Te design "guides the patient through the dosing regimen with innovative design aspects such as an area to note start date, a clear day 1 to 28 schedule, and 'non dosing days' being identifed with perforated circles that would then be punched out," says Hunter. Currently only one stock-keeping unit (SKU) for Galafold is marketed, with plans for further country launches. "One pack presentation will service all European markets, but with each European market having its native language and associated printed artwork," says Hunter. "Minimizing stock holding for smaller markets, Amicus has launched a Nordic pack—this is its frst multi-country/ multi-language pack. Implementation of further regionalised packs may prove useful to Amicus as the launch of Galafold is rolled out to more EU countries." Amicus is currently submitting regulatory applications in other markets, and it is envisioned that Almac will service those markets from its Craigavon facilities, he adds. Te wallet features built-in tamper-evident solutions and the capacity for serialized data to be applied. We could explain that all our creations come from more than 50 years' experience. We could tell you that we mainly work with local suppliers, or that our traditions inspire us to constantly improve our performance. But maybe all you need to know is that the technology you use is made by IMA. Visit us at Pack Expo 2016 November 6-9, 2016 - Chicago, USA South Hall - Booth # 3547 www.ima.it MEDIAMORPHOSIS.it - Ph. Fabio Mantovani More than home made. MADE IN IMA See us at Pharma Expo Booth #W-527 Almac Group has announced a $5.2 million investment and the creation of almost 80 new jobs across its Durham, NC, facilities. The company is currently celebrating 20 years in North America: In 1996, Almac opened its clinical trial operations in Audubon, PA, and by 2000, it had expanded its North American presence into North Carolina through the acquisition of Applied Clinical Concepts Inc (ACCI) and Duke Clinical Research Institute Pharmacy (DCRIP), which merged to form Clinical Trial Services based in the Research Triangle Park, Durham. "This latest investment and increase in capacity at our Durham facility is a sign of our continuing commitment to offer market driven solutions to our client base," said Donna Christopher, global vp operations, Almac Clinical Services, in a statement. "We are delighted to mark our 20th year in the U.S. with such a signifcant announcement— once again reinforcing our dedication to global expansion." The $5.2 million investment will see the expansion of its Clinical Services facility along with the development of its Diagnostics and Clinical Technologies operations based in the same area. Almac currently employs more than 1,600 individuals across six facilities in the United States and almost 3,000 people based in Europe and Asia. Almac expanding in the United States

Articles in this issue

Links on this page

Archives of this issue

view archives of PD_Packaging Digest - Packaging Digest, Fall 2016